Welcome
Support Centre
11 February 2012 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
mental health register
archived registers
all registers
tips on searching
 
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
The role of glutamate in the development of phantom limb pain
Source of recordUK Trials
ISRCTNISRCTN48374927
Date ISRCTN assigned01/03/2001
Local reference number(s)SP3481
Public titleThe role of glutamate in the development of phantom limb pain
Scientific title
AcronymN/A
Disease/condition/study domainPain
Study hypothesisNot provided at time of registration
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteria1. Patients undergoing lower limb amputation for peripheral vascular disease or as a result of complications of diabetes mellitus
2. Able to give informed consent and cooperate with pain assessment
Participants - exclusion criteriaNot provided at time of registration
Patient information material
Anticipated start date01/01/2001
Anticipated end date01/01/2007
Status of trialCompleted
Target number of participantsNot provided at time of registration
InterventionsAll patients will have spinal and epidural anaesthesia with bupivacaine established before amputation and will receive an epidural infusion of bupivacaine for 48 to 72 hours after surgery for postoperative analgesia.

Patients will be randomised to receive either:
1. An epidural bolus of ketamine before surgery followed by epidural ketamine infusion for 48 to 72 hours
2. A placebo
Primary outcome measure(s)Not provided at time of registration
Secondary outcome measure(s)Not provided at time of registration
PublicationsResults in http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17583431
Sources of fundingAction Medical Research (UK)
Sponsor nameAction Medical Research (UK)
Sponsor detailsVincent House
Horsham West Sussex
United Kingdom
RH12 2DP
Contact nameDr Alastair F Nimmo
Contact detailsUniversity of Edinburgh Department of Anaesthesia Critical Care and Pain Medicine
Royal Infirmary of Edinburgh
Lauriston Place
Edinburgh
United Kingdom
EH3 9YW
Contact telephone+44 (0)131 536 3652
Contact fax+44 (0)131 536 3672
Contact emaila.nimmo@ed.ac.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN48374927
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 Current Controlled Trials Ltd. Part of Springer Science+Business Media. | terms & conditions | privacy statement


BioMed Central